Events
Next events
Jul 7, 2019
Poster presentation:
Abstract Title: “Ir-CPI, a FXI/FXIIa inhibitor, provides an effective and safe thromboprotection during extracorporeal circulation associated with open-heart surgery”.
Presentation number: PB0051
Link: https://www.isth2019.org/
Melbourne, Australia
[Read more]Previous events
Jul 19, 2018
Poster presentation:
Abstract presentation number: PB503 - "Ir-CPI: an original inhibitor of thrombosis and thrombosis-associated with cancer"
Oral presentation:
"Ir-CPI a New Potent Inhibitor of Thrombosis and Thrombosis Associated with Cancer"
Link: http://www.ssc2018.org/
Dublin, Ireland
Jul 19, 2018
Oral presentation:
"Ir-CPI: an original inhibitor of thrombosis and thrombosis associated with cancer"
Link: http://www.ssc2018.org/
Dublin, Ireland
Jul 10, 2017
Abstract Title: "Efficacy of a Novel Contact Pathway Inhibitor, Ir-CPI, on in vitro Clotting Induced by PCI Catheter Segment"
Link: http://www.isth2017.org/
Berlin, Germany
May 1, 2016
Bioxodes to participate at the ISTH SCC 2016 annual congress.
Montpellier, France
Jun 1, 2015
Abstract titles :
“Efficacy of a novel contact pathway inhibitor, Ir-CPI, in an extracorporeal membrane oxygenator model” ECMO 2015.pdf
“Antithrombotic effects of Ir-CPI in an arterio-venous shunt model in the rabbit” AV-shunt 2015.pdf
“Evaluation of the effects of a novel contact pathway inhibitor, Ir-CPI, on in vitro platelet function and coagulation” Platelets 2015.pdf
Toronto, Canada